Elfazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401520This classification denotes an anxiolytic with the molecular formula C19H18ClFN2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RM53R5R2BL, chemically known as 7-chloro-1-(2-(ethylsulfonyl)ethyl)-5-(o-fluorophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one but generally known as elfazepam, which bears US NIH Compound Identifier 65445. European Medicines Agency schedules Elfazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06483MIG. The term ELFAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). ELFAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule elfazepam under HS 29339940 and SITC 51577. As of Q4 2014, ELFAZEPAM remains the US FDA Preferred Term for this commodity. Elfazepam bears US NLM identifiers UMLS ID C0059029 and NCI Concept Code C74184. SMILES: CLC1CC2C(N(CCS(=O)(=O)CC)C(=O)CN=C2C2C(F)CCCC2)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.